Back to search

Article

Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay

2024-07-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>INTRODUCTION</h4> Recent advancements in immunological methods accurately quantify biofluid biomarkers for identifying Alzheimer’s pathology and neurodegeneration. Despite this progress, more biomarkers, ideally in blood, are needed for effective patient management and disease monitoring for Alzheimer’s disease (AD) and other neurodegenerative proteinopathies. <h4>METHODS</h4> We employed the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7f21f4ca-f6b4-5198-b17f-c5811efd4841
DOI
10.1101/2024.07.29.24311079
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich AssayDOI 10.1101/2024.07.29.24311079
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s diseaseSemantic proximity
Multiplex plasma profiling of synaptic biomarkers in Alzheimer’s disease using NULISA: early alterations, APOE genotype effects, and pTau217 associationsSemantic proximity
Systems Approach to Neurodegenerative Disease Biomarker DiscoverySemantic proximity
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesSemantic proximity
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine ApproachSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity
Presymptomatic plasma biomarkers in autosomal dominant Alzheimer’s disease: sequence and timingSemantic proximity
Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseasesSemantic proximity
Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity
Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platformSemantic proximity
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity
Select a neighboring publication to make it the new centre.